Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cancer Centers of North Carolina (CCNC) was a leading community-based oncology and hematology practice providing comprehensive cancer care across several locations in North Carolina, including Raleigh, Cary, and Asheville. The center offered a wide range of services such as chemotherapy, radiation oncology, and participation in national clinical trials through its long-standing affiliation with The US Oncology Network. In 2015, the Raleigh-based operations of CCNC were acquired by Duke Raleigh Hospital, leading to its integration into the Duke Health system as Duke Cancer Center Macon Pond. The practice was recognized for its commitment to advanced cancer treatment and its significant role in clinical research within the Research Triangle region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Centers of North Carolina.